Back

Leads Biolabs wins Japan orphan designation for opamtistomig

Verifying
  • Leads Biolabs said Japan granted opamtistomig orphan designation for EP-NEC treatment.
  • September 28, 2026, marked opamtistomig’s third orphan designation after U.S. and European designations.
  • Opamtistomig is being evaluated across 14 indications, including a pivotal registrational study.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.